Find more information on the issues deeply affected by private equity investments:
Each month, PESP’s Healthcare Team will be putting together a roundup that shares the latest news stories related to private equity in healthcare and highlights the work that our team has published in the last month. In the…
In light of continued investor interest in healthcare and the risks associated with private equity ownership of healthcare companies, the Private Equity Stakeholder Project is tracking private equity-backed healthcare acquisitions. Below is a list of private equity healthcare buyouts,…
Private equity’s expansion into the clinical trial industry is accelerating and may reshape how medical studies are conducted and overseen. The growing consolidation of research sites and ethics review boards raises concerns about trial safety, the long-term…
States move to rein in private equity’s growing control of healthcare, new report finds Private Equity Stakeholder Project report tracks 2025 legislative wave targeting financial risks and ownership opacity in healthcare State lawmakers across the country advanced an unprecedented wave…
PESP Shares Concerns About Private Equity’s Role in Rising Healthcare Costs at Washington’s Health Care Cost Transparency Board On October 23, the Washington Health Care Cost Transparency Board (HCCTB) convened to examine the financial and structural pressures…
Last week, Bloomberg reported that Walgreens had cut pay for its retail employees following the drugstore’s $18.8 billion buyout by private equity firm Sycamore Partners. As Walgreens’ new owners look to cut costs, hourly workers…
Private equity has played a major role in the issue of surprise medical billing. The 2020 bipartisan No Surprises Act[1] attempted to address the issue of patients receiving high out-of-network bills after being treated at a supposedly in-network…
Each month, PESP’s Healthcare Team will be putting together a roundup that shares the latest news stories related to private equity in healthcare and highlights the work that our team has published in the last month. In the news…
In light of continued investor interest in healthcare and the risks associated with private equity ownership of healthcare companies, the Private Equity Stakeholder Project is tracking private equity-backed healthcare acquisitions. Below is a list of…
California has enacted two laws to curb investor influence in health care. Governor Gavin Newsom signed SB 351 and AB 1415 in October, reinforcing clinical independence and expanding…
On September 15, 2025, the Federal Trade Commission (FTC) announced that three directors from Sevita Health’s Board of Directors had resigned in response to an enforcement action on interlocking directorates. An interlocking directorate is when a member…
In light of continued investor interest in healthcare and the risks associated with private equity ownership of healthcare companies, the Private Equity Stakeholder Project is tracking private equity-backed healthcare acquisitions. Below is a list of private equity healthcare buyouts,…
